수의용 자동 혈당 측정기 시장 예측(2026-2032년)

The Veterinary Automatic Blood Glucose Meter Market is projected to grow by USD 1,401.84 million at a CAGR of 6.95% by 2032.

Veterinary Automatic Blood Glucose Meters Support Faster, More Consistent Monitoring

Veterinary automatic blood glucose meters are portable diagnostic devices used to measure glucose in animal blood, supporting clinical assessment and ongoing management of diabetes and other metabolic conditions. Their value is linked to rapid results, reduced dependence on laboratory workflows, and the ability to support monitoring in veterinary clinics, hospitals, and selected home-care settings. Adoption is influenced by measurement accuracy, species suitability, sample-volume requirements, ease of operation, connectivity, consumable availability, and compliance with veterinary diagnostic expectations.

Workflow Integration and Species-Specific Design Are Reshaping Adoption

The landscape is shifting from stand-alone measurement toward integrated point-of-care workflows. Veterinary providers increasingly prioritize devices that simplify sample handling, minimize operator steps, deliver clear alerts, and support electronic documentation. Species-specific calibration and validation remain important because hematocrit, plasma composition, and sampling practices can affect readings across dogs, cats, horses, livestock, and other animals. Demand is also shaped by preventive care, chronic disease management, expanding companion-animal services, and the need to reduce delays between testing and treatment decisions.

Artificial Intelligence Can Improve Quality Control, Interpretation, and Care Coordination

Artificial intelligence can strengthen the role of automatic glucose meters by identifying anomalous readings, detecting patterns across longitudinal measurements, and supporting alerts for possible hypoglycemia or hyperglycemia. When connected with practice-management systems, analytical tools may help organize trends, associate readings with medication and feeding records, and prioritize follow-up. However, AI should remain an assistive layer: reliable performance depends on representative veterinary data, transparent validation, secure data handling, clinician oversight, and clear separation between measurement, interpretation, and treatment decisions.

Regional Conditions Determine Veterinary Glucose-Monitoring Priorities

North America generally emphasizes advanced companion-animal care, connected clinical workflows, and home-monitoring support. Europe places strong importance on quality systems, animal welfare, interoperability, and regulatory compliance, while the European Union benefits from cross-border standards alongside national differences. Asia-Pacific combines sophisticated urban veterinary services with uneven access across markets; Japan, China, South Korea, India, and Australia reflect distinct infrastructure and practice patterns. Latin America is shaped by varying import conditions, affordability constraints, and concentration of specialized care in major cities. The Middle East shows demand linked to modern veterinary facilities and livestock health priorities, while Africa requires solutions suited to constrained laboratory access, variable electricity and connectivity, and mixed companion-animal and production-animal settings.

Economic and Institutional Groups Reveal Different Adoption Environments

ASEAN markets present a diverse mix of emerging companion-animal services, import dependence, and growing urban demand. BRICS economies combine substantial animal populations with varied regulatory, manufacturing, and clinical infrastructures. European Union members operate within shared regulatory frameworks but differ in reimbursement, procurement, and veterinary-practice organization. G7 countries generally have mature diagnostic ecosystems and stronger opportunities for digital integration, although workflow and privacy requirements remain important. GCC markets often prioritize high-quality private veterinary facilities, import reliability, and livestock-related services. NATO members span highly different veterinary systems, making alliance membership less determinative than national regulation, procurement structures, and clinical capacity.

Country-Level Priorities Range from Digital Integration to Access and Localization

Australia combines advanced veterinary services with geographic dispersion that can increase the value of portable monitoring. Brazil and Mexico face varied access conditions and opportunities linked to both companion animals and livestock. Canada and the United States emphasize clinical efficiency, chronic disease management, and connected records. China and India present large, diverse veterinary ecosystems requiring differentiated urban, rural, and institutional approaches. France, Germany, Italy, and Spain operate within European regulatory structures while retaining distinct procurement and practice patterns. The United Kingdom emphasizes established clinical workflows and governance. Japan and South Korea are positioned for technology-enabled veterinary care, with attention to usability and data integration. Russia's operating environment is shaped by domestic supply, regulatory, and distribution considerations.

Leaders Should Prioritize Validation, Workflow Fit, and Reliable Service Delivery

Industry leaders should first validate meters across relevant species, hematocrit ranges, sample types, and real-world clinical settings rather than relying only on laboratory performance. Product design should reduce training requirements, make error states understandable, and support secure data export without forcing practices into complex workflows. Supply planning should cover strips, lancets, calibration materials, maintenance, and technical support, especially in regions with distribution constraints. Partnerships with veterinary hospitals, universities, laboratories, and regulators can strengthen evidence generation. AI-enabled features should be introduced with documented performance thresholds, human review, cybersecurity controls, and clear communication about limitations.

Methodology Combines Secondary Review with Clinical and Regional Context

This executive summary uses the defined market scope of veterinary automatic blood glucose meters and organizes findings by technology, workflow, geography, economic grouping, and country context. The analysis emphasizes verifiable structural factors, including veterinary-care delivery, point-of-care testing requirements, regulatory considerations, connectivity, species-specific measurement challenges, and supply-chain conditions. It excludes market estimates, market sizing, market shares, forecasts, and company-specific claims. Interpretations should be validated against current regulatory documents, peer-reviewed veterinary evidence, procurement records, clinical interviews, and country-level distribution data before being used for investment or operational decisions.

Reliable, Usable Monitoring Will Define the Next Stage of Veterinary Glucose Care

Veterinary automatic blood glucose meters are most valuable when they produce dependable results within practical clinical workflows. Progress will depend less on automation alone than on species-appropriate validation, consumable availability, staff usability, interoperability, and responsible application of AI. Regional and national differences require adaptable commercialization and service models, while group-level comparisons should be treated as contextual rather than predictive. Leaders that combine measurement quality with strong evidence, secure digital integration, and dependable support will be better positioned to improve veterinary decision-making and ongoing animal care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Automatic Blood Glucose Meter Market, by Animal Type

• 7.1. Introduction
• 7.2. Cats
• 7.3. Dogs

8. Veterinary Automatic Blood Glucose Meter Market, by Product Type

• 8.1. Introduction
• 8.2. Handheld Meters
• 8.3. Stationary Meters

9. Veterinary Automatic Blood Glucose Meter Market, by Technology

• 9.1. Introduction
• 9.2. Continuous Glucose Monitoring
• 9.3. Discrete Testing Meters

10. Veterinary Automatic Blood Glucose Meter Market, by End User

• 10.1. Introduction
• 10.2. Home Use
• 10.3. Research Institutes
• 10.4. Veterinary Clinics
• 10.5. Veterinary Hospitals

11. Veterinary Automatic Blood Glucose Meter Market, by Distribution Channel

• 11.1. Introduction
• 11.2. Offline
  • 11.2.1. Pharmaceutical Retailers
  • 11.2.2. Specialty Stores
• 11.3. Online
  • 11.3.1. Direct Sales
  • 11.3.2. E-Commerce

12. Veterinary Automatic Blood Glucose Meter Market, by Region

• 12.1. Introduction
• 12.2. Asia-Pacific
• 12.3. North America
• 12.4. Latin America
• 12.5. Europe
• 12.6. Middle East
• 12.7. Africa

13. Veterinary Automatic Blood Glucose Meter Market, by Group

• 13.1. Introduction
• 13.2. ASEAN
• 13.3. GCC
• 13.4. European Union
• 13.5. BRICS
• 13.6. G7
• 13.7. NATO

14. Veterinary Automatic Blood Glucose Meter Market, by Country

• 14.1. Introduction
• 14.2. United States
• 14.3. Canada
• 14.4. Mexico
• 14.5. Brazil
• 14.6. United Kingdom
• 14.7. Germany
• 14.8. France
• 14.9. Russia
• 14.10. Italy
• 14.11. Spain
• 14.12. China
• 14.13. India
• 14.14. Japan
• 14.15. Australia
• 14.16. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. Market Concentration Analysis, 2025
  • 15.2.1. Concentration Ratio (CR)
  • 15.2.2. Herfindahl Hirschman Index (HHI)
• 15.3. Recent Developments & Impact Analysis, 2025
• 15.4. Product Portfolio Analysis, 2025
• 15.5. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Abbott Laboratories
• 16.2. AccuBioTech Co Ltd
• 16.3. ACON Laboratories Inc
• 16.4. Arkray Inc
• 16.5. Bayer AG
• 16.6. BioMerieux SA
• 16.7. Bionime Corporation
• 16.8. Diamond Diagnostics Inc
• 16.9. EKF Diagnostics Holdings plc
• 16.10. Erba Diagnostics Mannheim GmbH
• 16.11. F. Hoffmann-La Roche Ltd
• 16.12. GlucoRx Ltd
• 16.13. Heska Corporation
• 16.14. IDEXX Laboratories Inc
• 16.15. i-SENS Inc
• 16.16. MED TRUST Co Ltd
• 16.17. Nova Biomedical Corporation
• 16.18. Petnostics Inc
• 16.19. Randox Laboratories Ltd
• 16.20. Sinocare Inc
• 16.21. TaiDoc Technology Corporation
• 16.22. Terumo Corporation
• 16.23. VivaChek Laboratories Inc
• 16.24. Zoetis Inc

17. Key Experts